The short version
Concierge longevity clinics offer high-touch, lab-driven care to a small panel of members for a recurring fee — typically $2K–$10K up front plus medications, additional labs, and renewals. They're a real product for a real buyer. They're also not the only way to access peptide therapy, hormone optimization, or longitudinal bloodwork.
Four alternative model categories worth knowing:
| Model | What it's optimized for | Tradeoff |
|---|---|---|
| Per-protocol telehealth (e.g. Boswell) | Specific peptide protocol with prescriber oversight | Less continuous-relationship infrastructure |
| Hospital-based functional medicine | Integrated with full medical record + insurance | Limited peptide menu; longer scheduling |
| DIY + regular PCP | Lowest cost; you drive the labs | You're the project manager; less expert synthesis |
| Membership-model longevity (concierge alternatives) | Coaching + labs + adjunct therapies bundled | Annual fee; pay for relationship between visits |
What concierge clinics are optimized for
Concierge longevity clinics are optimized for the buyer who wants high-touch, comprehensive-bloodwork-driven care across many domains — hormones, metabolic health, inflammation, mitochondrial markers, genomics — and who values a small-panel relationship where the same clinician knows their data over years. The recurring fee funds the panel cap and the time the team spends between visits.
For that buyer, the concierge model is the product. You're paying for the relationship, not the prescription. The peptide is downstream of a much wider conversation.
Concierge clinics solve for breadth. Per-protocol platforms solve for depth on one thing.
Where concierge falls short for a different buyer
If you came in with a specific question — "I want BPC-157 for a tendon," "I want PT-141 for a defined window," "I want sermorelin to support sleep" — the concierge entry can feel like buying a full audit when you wanted a single prescription. The $3K–$10K up-front bar is doing real work to filter the panel, but it's a tax if your goal is narrower than what the model is built around. And the membership lock-in incentivizes ongoing engagement when "we're done, see you in two years" might be the right answer.
None of that makes concierge clinics bad. The model just has a buyer it's not built for, and increasingly that buyer is the one searching for "concierge longevity clinic alternatives."
What Boswell is built for
Boswell sits in the per-protocol-telehealth slice of the table above. A U.S.-licensed physician evaluates you for the specific peptide you're considering, writes the prescription if appropriate, and a 503A pharmacy compounds it. There's no membership, no panel cap, no recurring fee. If you want continuous-relationship care, a concierge or membership platform is probably the better fit. If you want a defined protocol with prescriber oversight, that's the slot Boswell fills.
How it works walks the sequence. Peptide therapy without a membership goes deeper on the pricing model. Direct comparisons live at Boswell vs. Lifeforce and Boswell vs. Marek Health.
Questions worth asking before any of them
- Am I trying to optimize broadly across many systems, or address a specific protocol?
- What's the all-in cost over 12 months — fees, labs, medications, renewals?
- Is the peptide marked up inside the membership, or priced separately at pharmacy cost?
- Who's the prescriber, and is the pharmacy a 503A in good standing?
- If my goal is met in four months, what does stopping look like?
Sources